Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Katrin Jedrysiak"'
Autor:
Olaf Bätz, David Petroff, Katrin Jedrysiak, Ingmar Wolffram, Thomas Berg, Jan Kramer, Johannes Wiegand
Publikováno v:
JHEP Reports, Vol 6, Iss 9, Pp 101122- (2024)
Background & Aims: A goal of the World Health Organization’s global hepatitis strategy is the elimination of chronic hepatitis C virus (HCV) infection by 2030. As part of its strategy, the Federal Joint Committee (Germany) decided to include hepati
Externí odkaz:
https://doaj.org/article/58af17b7917d4c709cbd098b34e0ae46
Autor:
David Petroff, Olaf Bätz, Katrin Jedrysiak, Anja Lüllau, Jan Kramer, Hjördis Möller, Renate Heyne, Burkhard Jäger, Thomas Berg, Johannes Wiegand
Publikováno v:
Pathogens, Vol 10, Iss 12, p 1570 (2021)
(1) Background: Low rates of hepatitis C virus (HCV) diagnosis and sub-optimal linkage to care constitute barriers toward eliminating the infection. In 2012/2013, we showed that HCV screening in primary care detects unknown cases. However, hepatitis
Externí odkaz:
https://doaj.org/article/90d3d7c6f96549f5b581b2c92d5188bd
Publikováno v:
Viruses, Vol 13, Iss 11, p 2327 (2021)
Linkage to care presents one obstacle toward eliminating HCV, and the current two-step pathway (anti-HCV, followed by HCV-RNA testing) results in the loss of patients. HCV screening was tested in the primary care setting with the fingerstick Xpert HC
Externí odkaz:
https://doaj.org/article/aa50216420354fc7959c8af6e466b524
Autor:
David Petroff, Ingmar Wolffram, Olaf Bätz, Katrin Jedrysiak, Jan Kramer, Thomas Berg, Johannes Wiegand
Publikováno v:
Liver International. 43:785-793
Screening strategies for undiagnosed infections are fundamental for hepatitis C virus (HCV) elimination. We previously investigated HCV prevalence and screening strategies in an urban primary care setting. IV drug abuse, blood transfusion before 1992
Publikováno v:
Clinical Gastroenterology and Hepatology. 20:641-650
Background & aims Upper levels of normal for alanine aminotransferase (ALT), aspartate aminotransferase (AST), and γ-glutamyltransferase (GGT) generally take sex into account, but not age. This simplification may lead to misclassification and burden
Autor:
Wiegand, David Petroff, Olaf Bätz, Katrin Jedrysiak, Anja Lüllau, Jan Kramer, Hjördis Möller, Renate Heyne, Burkhard Jäger, Thomas Berg, Johannes
Publikováno v:
Pathogens; Volume 10; Issue 12; Pages: 1570
(1) Background: Low rates of hepatitis C virus (HCV) diagnosis and sub-optimal linkage to care constitute barriers toward eliminating the infection. In 2012/2013, we showed that HCV screening in primary care detects unknown cases. However, hepatitis
Publikováno v:
Viruses; Volume 13; Issue 11; Pages: 2327
Linkage to care presents one obstacle toward eliminating HCV, and the current two-step pathway (anti-HCV, followed by HCV-RNA testing) results in the loss of patients. HCV screening was tested in the primary care setting with the fingerstick Xpert HC
Publikováno v:
Gut. 70:219-221
We read with interest the recent article by Newsome et al which provides guidelines for general practitioners on the management of abnormal liver blood tests based on the clinical recognition pattern of elevated liver enzymes and recommendations on n
Publikováno v:
Viruses, Vol 13, Iss 2327, p 2327 (2021)
Viruses
Viruses
Linkage to care presents one obstacle toward eliminating HCV, and the current two-step pathway (anti-HCV, followed by HCV-RNA testing) results in the loss of patients. HCV screening was tested in the primary care setting with the fingerstick Xpert HC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ec10540709bbcd766476424399c2993b
https://ul.qucosa.de/id/qucosa:85408
https://ul.qucosa.de/id/qucosa:85408
Autor:
Ingmar, Wolffram, David, Petroff, Olaf, Bätz, Katrin, Jedrysiak, Jan, Kramer, Hannelore, Tenckhoff, Thomas, Berg, Johannes, Wiegand, T, Kottmann
Publikováno v:
Journal of Hepatology. 62:1256-1264
Background & Aims Prevalence data for hepatitis B and C and an evaluation of a guideline based screening in the primary care setting are not yet available. We therefore implemented a hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus (HCV